Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
2.530
+0.110 (4.55%)
At close: May 12, 2025, 4:00 PM
2.600
+0.070 (2.77%)
After-hours: May 12, 2025, 6:50 PM EDT
Vigil Neuroscience Market Cap
Vigil Neuroscience has a market cap or net worth of $118.08 million as of May 12, 2025. Its market cap has increased by 13.42% in one year.
Market Cap
118.08M
Enterprise Value
33.23M
1-Year Change
13.42%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since the IPO on January 7, 2022, Vigil Neuroscience's market cap has decreased from $395.70M to $118.08M, a decrease of -70.16%. That is a compound annual growth rate of -30.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 112.95M | 62.70% |
| Dec 31, 2024 | 69.42M | -42.76% |
| Dec 29, 2023 | 121.27M | -72.73% |
| Dec 30, 2022 | 444.76M | 12.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |